Evidence map›Paper›PMID 25704817›Full record

ArticleCell reports2015

Feedback inhibition of CREB signaling promotes beta cell dysfunction in insulin resistance.

Emilie Blanchet, Sam Van de Velde, Shigenobu Matsumura, Ergeng Hao, John LeLay, Klaus Kaestner, Marc Montminy

Open access · goldAbstract read
In one paragraph

Article in Cell reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed
4.4field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 76 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. PKIB, a Novel Target for Cancer Therapy.International journal of molecular sciences · 2024
    Review
  7. Adipose Tissue Hypoxia in Obesity: Clinical Reappraisal of Hypoxia Hypothesis.Advances in experimental medicine and biology · 2024
    Review
  8. CaFrontiers in endocrinology · 2024
    Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Emilie BlanchetPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Sam Van de VeldePeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Shigenobu MatsumuraPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
Ergeng HaoPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA.
John LeLayPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA; Department of Genetics, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104-5156, USA.
Klaus KaestnerPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA; Department of Genetics, Institute for Diabetes, Obesity and Metabolism, University of Pennsylvania School of Medicine, 3400 Civic Center Boulevard, Philadelphia, PA 19104-5156, USA.
Marc MontminyPeptide Biology Laboratories, Salk Institute, 10010 North Torrey Pines Road, La Jolla, CA 92037, USA. Electronic address: montminy@salk.edu.
University of Pennsylvania · US

Funding

ZINC FINGER PROTEINS IN EARLY KIDNEY DEVELOPMENTP01DK049210 · NIDDK · UNIVERSITY OF PENNSYLVANIA · PI KAESTNER, KLAUS H · 1995 to 2016
$26.9M
Role of the TORC/CRTC Family of Coactivators in Energy BalanceR01DK049777 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MONTMINY, MARC R · 1995 to 2014
$5.6M
Regulation of Hepatic Gluconeogenesis by the CREB:TORC2 PathwayR01DK083834 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MONTMINY, MARC R · 2009 to 2022
$3.7M
Cross-talk between the circadian clock and the cAMP signaling pathwayR01DK091618 · NIDDK · SALK INSTITUTE FOR BIOLOGICAL STUDIES · PI MONTMINY, MARC R, PANDA, SATCHIDANANDA · 2011 to 2015
$3.2M
NIDDK NIH HHS P01 DK049210NIDDK NIH HHS P01-DK049210NIDDK NIH HHS R01 DK049777NIDDK NIH HHS R01-DK049777NIDDK NIH HHS R01 DK083834NIDDK NIH HHS R01-DK083834NIDDK NIH HHS R01 DK091618NIDDK NIH HHS R01-DK091618
6 · The paper itself

Abstract

Although persistent elevations in circulating glucose concentrations promote compensatory increases in pancreatic islet mass, unremitting insulin resistance causes deterioration in beta cell function that leads to the progression to diabetes. Here, we show that mice with a knockout of the CREB coactivator CRTC2 in beta cells have impaired oral glucose tolerance due to decreases in circulating insulin concentrations. CRTC2 was found to promote beta cell function in part by stimulating the expression of the transcription factor MafA. Chronic hyperglycemia disrupted cAMP signaling in pancreatic islets by activating the hypoxia inducible factor (HIF1)-dependent induction of the protein kinase A inhibitor beta (PKIB), a potent inhibitor of PKA catalytic activity. Indeed, disruption of the PKIB gene improved islet function in the setting of obesity. These results demonstrate how crosstalk between nutrient and hormonal pathways contributes to loss of pancreatic islet function.

Indexed as

Insulin ResistanceAnimalsCell Line, TumorCyclic AMPCyclic AMP Response Element-Binding ProteinGlucose Tolerance TestHypoxia-Inducible Factor 1InsulinInsulin-Secreting CellsIntracellular Signaling Peptides and ProteinsIslets of LangerhansMaf Transcription Factors, LargeMaleMiceMice, Inbred C57BLMice, KnockoutCreb1 protein, mouseCrtc2 protein, mouseCyclic AMPCyclic AMP Response Element-Binding ProteinHypoxia-Inducible Factor 1InsulinIntracellular Signaling Peptides and ProteinsMafa protein, mouseMaf Transcription Factors, LargeTranscription Factors

Identifiers

PMID25704817
PMCPMC4872509
OpenAlexW2063335422

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.